Celltrion Wins Brazilian Trastuzumab and Rituximab Tender

As Company Aims to Lead Latin American Biosimilar Market

 
• By Akriti Seth
  
Brazil
Celltrion has won the Brazilian contract for anticancer therapeutics for the second year in a row • Source: Alamy (Alamy Stock Photo)
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products